Development of an assay for the detection of mucopolysaccharidosis type VI patients using dried blood-spots

Clinica Chimica Acta

Volumn 353, Issue 1-2, 2005, Pages 67-74

  Hein, Leanne K ^a   Meikle, Peter J ^a,b   Dean, Caroline J ^a   Bockmann, Michelle R ^a   Auclair, Dyane ^a   Hopwood, John J ^a,b   Brooks, Doug A ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Blood spots; Immune assay; Lysosomal storage disorder; Maroteaux Lamy syndrome; Mucopolysaccharidosis type VI; N Acetylgalactosamine 4 sulfatase

Indexed keywords

4 SULFATASE; N ACETYLGALACTOSAMINE 4 SULFATASE; PROTEIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DIAGNOSTIC ACCURACY; ENZYME DEFICIENCY; ENZYME REPLACEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; MORQUIO SYNDROME; NONHUMAN; PATHOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; SKELETON MALFORMATION;

EID: 13444282110     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.10.009     Document Type: Article

References (28)

1. E.F. Neufeld, and J. Muenzer The mucopolysaccharidoses C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The Metabolic and Molecular Basis of Inherited Diseases 8th ed. 2001 McGraw-Hill New York (USA) 3421 3452
2. P.J. Meikle, J.J. Hopwood, A.E. Clague, and W.F. Carey Prevalence of lysosomal storage disorders JAMA 281 1999 249 254
3. T. Litjens, D.A. Brooks, C. Peters, G.J. Gibson, and J.J. Hopwood Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS VI patients Am. J. Hum. Genet. 58 1996 1127 1134
4. G.R.D. Villani, N. Balzano, D. Vitale, M. Saviano, V. Pavone, and P. Di Natale Maroteaux-Lamy syndrome: five novel mutations and their structural localization Biochim. Biophys. Acta 1453 1999 185 192
5. E.Y. Voskoboeva, X.D. Krasnopolskaya, K. Peters, and K. von Figura Identification of mutations in the arylsulfatase B gene in Russian patients with type VI mucopolysaccharidosis Russ. J. Genet. 36 2000 689 694
6. T. Litjens, and J.J. Hopwood Mucopolysaccharidosis type VI: structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase Hum. Mutat. 18 2001 282 295
7. L. Karageorgos, P. Harmatz, J. Simon, A. Pollard, P.R. Clements, and D.A. Brooks Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy Hum. Mutat. 23 2004 229 233
8. M.M. McGovern, M.D. Ludman, M.P. Short, L. Steinfeld, M. Kattan, and E.L. Raab Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): status 40 months after BMT Birth Defects Orig. Artic. Ser. 22 1986 41 53
9. E. Herskhovitz, E. Young, J. Rainer, C.M. Hall, V. Lidchi, and K. Chong Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up J. Inherit Metab. Dis. 22 1999 50 62
10. P.F. Jezyk, M.E. Haskins, D.F. Patterson, W.J. Mellman, and M. Greenstein Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome Science 198 1977 834 836
11. M.E. Haskins, G.D. Aguirre, P.F. Jezyk, and D.F. Patterson The pathology of the feline model of mucopolysaccharidosis VI Am. J. Pathol. 101 1980 657 674
12. A.C. Crawley, D.A. Brooks, V.J. Muller, B.A. Petersen, E.L. Isaac, and J. Bielicki Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome J. Clin. Invest. 97 1996 1864 1873
13. A.C. Crawley, K.H. Niedzielski, E.L. Isaac, R.C. Davey, S. Byers, and J.J. Hopwood Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI J. Clin. Invest. 99 1997 651 662
14. S. Byers, J.D. Nuttall, A.C. Crawley, J.J. Hopwood, K. Smith, and N.L. Fazzalari Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI Bone 21 1997 425 431
15. D. Auclair, J.J. Hopwood, D.A. Brooks, J.F. Lemontt, and A.C. Crawley Replacement therapy in mucopolysaccharidosis type VI: advantages of early onset of therapy Mol. Genet. Metab. 78 2003 163 174
16. P. Harmatz, C.B. Whitley, L. Waber, R. Pais, R. Steiner, and B. Plecko A phase I/II study of enzyme replacement therapy (ERT) for mucopolysaccharidosis VI (MPS VI; Maroteaux-Lamy syndrome): 48 week progress report Am. J. Hum. Genet. 71 2002 582
17. P. Harmatz, D. Ketteridge, R. Steiner, J. Simon, J. Waterson, and S. Oates A phase I open-label clinical study of efficacy and safety of recombinant human N-acetylgalactosamine 4-sulfatase (rhASB) enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) Am. J. Hum. Genet. 73 2003 623
18. P. Harmatz, C.B. Whitley, L. Waber, R. Pais, R. Steiner, and B. Plecko Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) J. Pediatr. 144 2004 574 580
19. J.J. Hopwood, and J.R. Harrison High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses Anal. Biochem. 119 1982 120 127
20. D.A. Brooks, P.A.G. McCourt, G.J. Gibson, L.J. Ashton, M. Shutter, and J.J. Hopwood Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients Am. J. Hum. Genet. 48 1991 710 719
21. D.S. Anson, J.A. Taylor, J. Bielicki, G.S. Harper, C. Peters, and G.J. Gibson Correction of human mucopolysaccharidosis type-VI fibroblast with recombinant N-acetylgalactosamine-4-sulphatase Biochem. J. 284 1992 789 794
22. G. Yogalingam, T. Litjens, J. Bielicki, A.C. Crawley, V. Muller, and D.S. Anson Feline mucopolysaccharidosis type VI. Characterization of recombinant N-acetylgalactosamine 4-sulfatase and identification of a mutation causing the disease J. Biol. Chem. 271 1996 27259 27265
23. G.J. Gibson, G.TP. Saccone, D.A. Brooks, P.R. Clements, and J.J. Hopwood Human N-acetylgalactosamine 4-sulphate sulphatase: purification, monoclonal antibody production and native and subunit Mr values Biochem. J. 248 1987 755 764
24. D.A. Brooks, G.J. Gibson, and J.J. Hopwood Immunochemical characterization of feline and human N-acetylgalactosamine 4-sulfatase Biochem. Med. Metabol. Biol. 53 1994 58 66
25. K. Umapathysivam, A.M. Whittle, E. Ranieri, C. Bindloss, E.M. Ravenscroft, and O.P. van Diggelen Determination of acid α-glucosidase protein: evaluation as a screening marker for Pompe disease and other lysosomal storage disorders Clin. Chem. 46 2000 1318 1325
26. J.J. Hopwood, V. Muller, J.R. Harrison, W.F. Carey, H. Elliot, and E.F. Robertson Enzymatic diagnosis of the mucopolysaccharidoses: experience of 96 cases diagnosed in a five-year period Med. J. Aust. 1 1982 257 260
27. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with Folin Phenol reagent J. Biol. Chem. 193 1951 265 275
28. N.A. Chamoles, M.B. Blanco, D. Gaggioli, and C. Casentini Hurler-like phenotype: enzymatic diagnosis in dried blood spots on filter paper Clin. Chem. 47 2001 2098 2102